Biofourmis develops and delivers clinically validated software-based therapeutics to provide cost-effective solutions for payers, accelerated research and drug development for biopharmaceutical companies, advanced tools for clinicians to deliver personalized care, and, ultimately, better outcomes for patients.
At the heart of Biofourmis is our clinically-proven and FDA-cleared Biovitals® Platform. It is a highly sophisticated AI-powered health analytics ecosystem that predicts clinical exacerbation in advance of a critical event. It allows clinicians to deliver more personalized care and enables better patient outcomes.
In a two-week period, this startup created a remote monitoring system that has a biosensor for a patient’s arm and an AI application to help with the diagnosis. In other words, this can help reduce infection rates for doctors and medical support personnel.
Company Type: Enterprise
Region: US & Canada
Product: Biovitals Platform
33 Arch St
Boston, MA 02110